Your browser doesn't support javascript.
loading
2% chlorhexidine-70% isopropyl alcohol versus 10% povidone-iodine for insertion site cleaning before central line insertion in preterm infants: a randomised trial.
Kieran, Emily A; O'Sullivan, Anne; Miletin, Jan; Twomey, Anne R; Knowles, Susan J; O'Donnell, Colm Patrick Finbarr.
Afiliación
  • Kieran EA; Department of Neonatology, The National Maternity Hospital, Dublin, Ireland.
  • O'Sullivan A; National Children's Research Centre, Dublin, Ireland.
  • Miletin J; School of Medicine, University College Dublin, Dublin, Ireland.
  • Twomey AR; Department of Neonatology, Coombe Women and Infants University Hospital, Dublin, Ireland.
  • Knowles SJ; Department of Neonatology, Coombe Women and Infants University Hospital, Dublin, Ireland.
  • O'Donnell CPF; Department of Neonatology, The National Maternity Hospital, Dublin, Ireland.
Arch Dis Child Fetal Neonatal Ed ; 103(2): F101-F106, 2018 Mar.
Article en En | MEDLINE | ID: mdl-29074717
ABSTRACT

OBJECTIVE:

To determine whether 2% chlorhexidine gluconate-70% isopropyl alcohol (CHX-IA) is superior to 10% aqueous povidone-iodine (PI) in preventing catheter-related blood stream infection (CR-BSI) when used to clean insertion sites before placing central venous catheters (CVCs) in preterm infants.

DESIGN:

Randomised controlled trial.

SETTING:

Two neonatal intensive care units (NICUs). PATIENTS Infants <31 weeks' gestation who had a CVC inserted.

INTERVENTIONS:

Insertion site was cleaned with CHX-IA or PI. Caregivers were not masked to group assignment. MAIN OUTCOME

MEASURES:

Primary outcome was CR-BSI determined by one microbiologist who was masked to group assignment. Secondary outcomes included skin reactions to study solution and thyroid dysfunction.

RESULTS:

We enrolled 304 infants (CHX-IA 148 vs PI 156) in whom 815 CVCs (CHX-IA 384 vs PI 431) were inserted and remained in situ for 3078 (CHX-IA 1465 vs PI 1613) days. We found no differences between the groups in the proportion of infants with CR-BSI (CHX-IA 7% vs PI 5%, p=0.631), the proportion of CVCs complicated by CR-BSI or the rate of CR-BSI per 1000 catheter days. Skin reaction rates were low (<1% CVC insertion episodes) and not different between the groups. More infants in the PI group had raised thyroid-stimulating hormone levels and were treated with thyroxine (CHX-IA 0% vs PI 5%, p=0.003).

CONCLUSIONS:

We did not find a difference in the rate of CR-BSI between preterm infants treated with CHX-IA and PI, and more infants treated with PI had thyroid dysfunction. However, our study was not adequately powered to detect a difference in our primary outcome and a larger trial is required to confirm our findings. TRIAL REGISTRATION This study was registered with the EU clinical trials register before the first patient was enrolled (Eudract 2011-002962-19). (https//www.clinicaltrialsregister.eu).
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Povidona Yodada / Cateterismo Venoso Central / Clorhexidina / 2-Propanol / Infecciones Relacionadas con Catéteres / Antiinfecciosos Locales Tipo de estudio: Clinical_trials Idioma: En Revista: Arch Dis Child Fetal Neonatal Ed Asunto de la revista: PEDIATRIA / PERINATOLOGIA Año: 2018 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Povidona Yodada / Cateterismo Venoso Central / Clorhexidina / 2-Propanol / Infecciones Relacionadas con Catéteres / Antiinfecciosos Locales Tipo de estudio: Clinical_trials Idioma: En Revista: Arch Dis Child Fetal Neonatal Ed Asunto de la revista: PEDIATRIA / PERINATOLOGIA Año: 2018 Tipo del documento: Article